Braskem S.A.(BAK)Earnings, Financials & Key Ratios
BAK•NYSE
$3.70
$638M mkt cap·Price updated May 7, 2026
AboutBraskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.Show more
- Revenue$77.41B+9.7%
- EBITDA$4.77B+37.9%
- Net Income-$11.32B-147.2%
- EPS (Diluted)-28.40-147.0%
- Gross Margin7.75%+81.0%
- EBITDA Margin6.16%+25.7%
- Operating Margin1.31%+152.7%
- Net Margin-14.62%-125.4%
- ROIC1.47%+153.9%
- Interest Coverage0.19+150.9%
BAK Key Insights
Braskem S.A. (BAK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
BAK Price & Volume
Braskem S.A. (BAK) stock price & volume — 10-year historical chart
Loading chart...
BAK Growth Metrics
Braskem S.A. (BAK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.34%
5 Years8.15%
3 Years-9.84%
TTM-1.58%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM27.7%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM27.77%
Return on Capital
10 Years22.45%
5 Years27.16%
3 Years2.7%
Last Year1.44%
BAK Recent Earnings
Braskem S.A. (BAK) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (64%)●Beat Revenue 4/12 qtrs (36%)
Q2 2026Latest
Mar 27, 2026EPS
$0.48
Est $0.98
+51.0%
Revenue
$3.0B
Est $3.1B
-3.7%
Q4 2025
Nov 11, 2025EPS
$0.02
Est $0.48
+95.8%
Revenue
$3.2B
Est $3.3B
-2.0%
Q3 2025
Aug 7, 2025EPS
$0.14
Est $0.70
+80.0%
Revenue
$3.3B
Est $3.3B
-1.3%
Q2 2025
May 12, 2025EPS
$0.30
Est $0.03
+900.0%
Revenue
$3.3B
Est $3.5B
-5.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 27, 2026 | $0.48vs $0.98+51.0% | $3.0Bvs $3.1B-3.7% |
| Q4 2025 | Nov 11, 2025 | $0.02vs $0.48+95.8% | $3.2Bvs $3.3B-2.0% |
| Q3 2025 | Aug 7, 2025 | $0.14vs $0.70+80.0% | $3.3Bvs $3.3B-1.3% |
| Q2 2025 | May 12, 2025 | $0.30vs $0.03+900.0% | $3.3Bvs $3.5B-5.6% |
Based on last 12 quarters of dataView full earnings history →
BAK Peer Comparison
Braskem S.A. (BAK) competitors in Petrochemicals, plastics and oxygenates — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LYB | 23.04B | 71.50 | -30.43 | -25.18% | -3.44% | -7.2% | 1.56 | |
 WLK | 12.47B | 97.38 | -8.30 | -8.01% | -14.91% | -16.76% | 0.69 | |
 OLN | 3.05B | 26.76 | -72.32 | 3.68% | -1.89% | -6.64% | 1.76 | |
 TROX | 1.34B | 8.41 | -2.83 | -5.73% | -12.3% | -30.42% | 2.48 | |
 AVNT | 3.35B | 36.50 | 41.01 | 0.61% | 4.81% | 6.59% | 0.81 | |
 DOW | 26.86B | 37.32 | -10.11 | -6.97% | -7.02% | -15.35% | 1.12 | |
 LIN | 228.85B | 493.85 | 33.85 | 2.97% | 20.56% | 17.82% | 0.68 | |
 EMN | 8.43B | 73.69 | 17.97 | -6.71% | 4.62% | 6.69% | 0.84 |
Compare BAK vs Peers
Braskem S.A. (BAK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BAK Income Statement
Braskem S.A. (BAK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 47.66B | 49.26B | 58B | 52.32B | 58.54B | 105.63B | 96.52B | 70.57B | 77.41B | 73.77B |
| Revenue Growth % | 0.81% | 3.35% | 17.74% | -9.79% | 11.89% | 80.42% | -8.62% | -26.89% | 9.7% | -1.58% |
| Cost of Goods Sold | 34.94B | 36.4B | 46.41B | 45.88B | 47.45B | 73.57B | 85.16B | 67.55B | 71.41B | 70.51B |
| COGS % of Revenue | 73.31% | 73.89% | 80.01% | 87.68% | 81.05% | 69.65% | 88.23% | 95.72% | 92.25% | - |
| Gross Profit | 12.72B▲ 0% | 12.86B▲ 1.1% | 11.59B▼ 9.9% | 6.44B▼ 44.4% | 11.1B▲ 72.2% | 32.06B▲ 188.9% | 11.36B▼ 64.6% | 3.02B▼ 73.4% | 6B▲ 98.5% | 3.25B▲ 0% |
| Gross Margin % | 26.69% | 26.11% | 19.99% | 12.32% | 18.95% | 30.35% | 11.77% | 4.28% | 7.75% | 4.41% |
| Gross Profit Growth % | 22.57% | 1.07% | -9.86% | -44.41% | 72.18% | 188.91% | -64.57% | -73.4% | 98.51% | - |
| Operating Expenses | 6.55B | 3.06B | 3.73B | 6.28B | 4.08B | 4.88B | 5.25B | 4.77B | 4.99B | 5.34B |
| OpEx % of Revenue | 13.74% | 6.21% | 6.43% | 11.99% | 6.96% | 4.62% | 5.44% | 6.76% | 6.44% | - |
| Selling, General & Admin | 2.89B | 2.89B | 3.55B | 4.01B | 3.77B | 4.58B | 4.87B | 4.39B | 4.63B | 4.82B |
| SG&A % of Revenue | 6.06% | 5.87% | 6.13% | 7.66% | 6.44% | 4.33% | 5.05% | 6.22% | 5.98% | - |
| Research & Development | 162.01M | 167M | 199.82M | 247.73M | 250.65M | 297M | 374M | 383M | 463M | 498M |
| R&D % of Revenue | 0.34% | 0.34% | 0.34% | 0.47% | 0.43% | 0.28% | 0.39% | 0.54% | 0.6% | - |
| Other Operating Expenses | 3.5B | 0 | 0 | 2.02B | 55.25M | 0 | 0 | 0 | -108M | -1000K |
| Operating Income | 5.95B▲ 0% | 9.36B▲ 57.3% | 8.3B▼ 11.3% | 169.09M▼ 98.0% | 7.02B▲ 4051.1% | 27.18B▲ 287.3% | 6.11B▼ 77.5% | -1.75B▼ 128.6% | 1.01B▲ 157.8% | -2.09B▲ 0% |
| Operating Margin % | 12.49% | 19% | 14.32% | 0.32% | 11.99% | 25.73% | 6.33% | -2.48% | 1.31% | -2.83% |
| Operating Income Growth % | -15.61% | 57.26% | -11.27% | -97.96% | 4051.08% | 287.26% | -77.51% | -128.63% | 157.83% | - |
| EBITDA | 8.81B | 12.39B | 11.38B | 3.8B | 10.28B | 31.36B | 10.85B | 3.46B | 4.77B | 2.75B |
| EBITDA Margin % | 18.49% | 25.15% | 19.63% | 7.27% | 17.56% | 29.69% | 11.24% | 4.9% | 6.16% | 3.72% |
| EBITDA Growth % | -3.88% | 40.62% | -8.12% | -66.61% | 170.46% | 205.03% | -65.42% | -68.13% | 37.91% | -45.5% |
| D&A (Non-Cash Add-back) | 2.86B | 3.03B | 3.08B | 3.63B | 3.26B | 4.18B | 4.73B | 5.21B | 3.75B | 4.83B |
| EBIT | 2.53B | 8.51B | 6.19B | -1.69B | 6.9B | 21.15B | 3.38B | -1.94B | -1.06B | -1.3B |
| Net Interest Income | -2.88B | -3.14B | -2.42B | -636.87M | -615.9M | -2.75B | -2.28B | -3.91B | -4.18B | -4.3B |
| Interest Income | 504.5M | 512.05M | 530.01M | 179.62M | 93.26M | 440M | 1.05B | 873M | 1.26B | 968.67M |
| Interest Expense | 2.15B | 2.36B | 2.23B | 816.49M | 709.17M | 3.19B | 3.33B | 4.78B | 5.44B | 5.27B |
| Other Income/Expense | -6.09B | -4.34B | -4.18B | -4.77B | -16.7B | -9.22B | -6.07B | -4.44B | -18.75B | -8.54B |
| Pretax Income | -140.01M▲ 0% | 5.42B▲ 3969.0% | 3.65B▼ 32.6% | -4.6B▼ 226.0% | -9.68B▼ 110.4% | 17.96B▲ 285.5% | 47M▼ 99.7% | -6.19B▼ 13274.5% | -17.73B▼ 186.4% | -10.63B▲ 0% |
| Pretax Margin % | -0.29% | 11% | 6.3% | -8.8% | -16.54% | 17% | 0.05% | -8.77% | -22.91% | -14.42% |
| Income Tax | 616.05M | 1.29B | 745.29M | -1.96B | -2.67B | 4B | 868M | -1.3B | -5.68B | -4.82B |
| Effective Tax Rate % | -440% | 23.85% | 20.4% | 42.64% | 27.56% | 22.26% | 1846.81% | 21.03% | 32.04% | 45.28% |
| Net Income | -411.47M▲ 0% | 4.08B▲ 1092.3% | 2.87B▼ 29.8% | -2.54B▼ 188.6% | -6.69B▼ 163.4% | 13.98B▲ 309.0% | -336M▼ 102.4% | -4.58B▼ 1262.8% | -11.32B▼ 147.2% | -5.24B▲ 0% |
| Net Margin % | -0.86% | 8.29% | 4.94% | -4.86% | -11.43% | 13.24% | -0.35% | -6.49% | -14.62% | -7.1% |
| Net Income Growth % | -113.1% | 1092.29% | -29.79% | -188.64% | -163.35% | 308.99% | -102.4% | -1262.8% | -147.22% | 27.7% |
| Net Income (Continuing) | -756.06M | 3.91B | 2.91B | -2.64B | -7.02B | 13.96B | -821M | -4.89B | -12.05B | -5.82B |
| Discontinued Operations | 26.86M | 8.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -1.02B | -827.5M | -876.4M | -233.82M | -320.4M | -1.66B | -1.21B | -713M | 504M | 360M |
| EPS (Diluted) | -1.04▲ 0% | 9.70▲ 1032.7% | 7.20▼ 25.8% | -6.64▼ 192.2% | -17.62▼ 165.4% | 35.08▲ 299.1% | -2.06▼ 105.9% | -11.50▼ 458.3% | -28.40▼ 147.0% | -13.15▲ 0% |
| EPS Growth % | -113.79% | 1032.69% | -25.77% | -192.22% | -165.36% | 299.09% | -105.87% | -458.25% | -146.96% | 27.77% |
| EPS (Basic) | -1.04 | 9.70 | 7.20 | -6.64 | -17.62 | 35.12 | -2.06 | -11.50 | -28.40 | - |
| Diluted Shares Outstanding | 397.72M | 398.01M | 398M | 397.99M | 398M | 398.61M | 398.6M | 398.35M | 398.6M | 398.48M |
| Basic Shares Outstanding | 397.72M | 397.87M | 397.87M | 397.99M | 398M | 398.11M | 398.24M | 398.35M | 398.6M | 398.48M |
| Dividend Payout Ratio | - | 24.46% | 52.32% | - | - | 42.85% | - | - | - | - |
BAK Balance Sheet
Braskem S.A. (BAK) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 16.26B | 17.42B | 21.38B | 5.81B | 6.58B | 39.29B | 34.46B | 37.44B | 37.04B | 26.27B |
| Cash & Short-Term Investments | 7.47B | 6.08B | 7.93B | 2.75B | 3.37B | 12.17B | 14.76B | 19.14B | 16.77B | 7.41B |
| Cash Only | 6.7B | 3.78B | 5.55B | 2.33B | 2.67B | 8.68B | 12.47B | 14.19B | 14.99B | 6.66B |
| Short-Term Investments | 764.86M | 485.78M | 49.63M | 419.5M | 698.32M | 3.49B | 2.29B | 4.96B | 1.79B | 745M |
| Accounts Receivable | 1.63B | 3.28B | 3.08B | 1.14B | 1.53B | 10.75B | 5.51B | 5.63B | 3.56B | 3.11B |
| Days Sales Outstanding | 12.51 | 24.31 | 19.35 | 7.95 | 9.57 | 37.15 | 20.83 | 29.11 | 16.8 | 24.41 |
| Inventory | 5.24B | 6.64B | 8.49B | 1.9B | 1.61B | 16.27B | 13.91B | 12.38B | 13.47B | 12.65B |
| Days Inventory Outstanding | 54.72 | 66.58 | 66.75 | 15.08 | 12.42 | 80.73 | 59.6 | 66.87 | 68.86 | 69.43 |
| Other Current Assets | 1.82B | 1.29B | 1.66B | 0 | 0 | 33.82M | 158M | 137M | 3.02B | 3.1B |
| Total Non-Current Assets | 35.57B | 35.31B | 37.81B | 11.12B | 9.99B | 53.27B | 53.59B | 54.3B | 64.54B | 61.11B |
| Property, Plant & Equipment | 29.34B | 29.76B | 31.76B | 8.68B | 7.48B | 40.01B | 41.72B | 42.23B | 44.14B | 41.6B |
| Fixed Asset Turnover | 1.62x | 1.66x | 1.83x | 6.03x | 7.83x | 2.64x | 2.31x | 1.67x | 1.75x | 1.74x |
| Goodwill | 2.06B | 2.06B | 2.06B | 511.81M | 396.38M | 2.06B | 2.09B | 2.17B | 2.18B | 0 |
| Intangible Assets | 750.21M | 668.62M | 682.11M | 174.81M | 148.21M | 818.42M | 935M | 935M | 1.21B | 3.04B |
| Long-Term Investments | 121.62M | 144.26M | 112.62M | 423.69M | 60.25M | 75.77M | 149M | 165M | 438M | 1.94B |
| Other Non-Current Assets | 3.3B | 2.68B | 3.2B | 668.6M | 267.71M | 2.06B | 2.35B | 2.36B | 2.69B | 24.66B |
| Total Assets | 51.82B▲ 0% | 52.73B▲ 1.8% | 59.19B▲ 12.3% | 16.94B▼ 71.4% | 16.57B▼ 2.1% | 92.56B▲ 458.5% | 88.05B▼ 4.9% | 91.74B▲ 4.2% | 101.58B▲ 10.7% | 87.38B▲ 0% |
| Asset Turnover | 0.92x | 0.93x | 0.98x | 3.09x | 3.53x | 1.14x | 1.10x | 0.77x | 0.76x | 0.79x |
| Asset Growth % | -14.52% | 1.76% | 12.25% | -71.39% | -2.14% | 458.52% | -4.88% | 4.19% | 10.72% | 1.11% |
| Total Current Liabilities | 23.04B | 18.56B | 23.12B | 4.03B | 5.47B | 25.19B | 24.19B | 24.49B | 28.27B | 22.35B |
| Accounts Payable | 6.55B | 5.06B | 8.34B | 2.27B | 1.91B | 12.05B | 12.25B | 13.22B | 16.88B | 13.87B |
| Days Payables Outstanding | 68.37 | 50.73 | 65.6 | 18.03 | 14.73 | 59.8 | 52.49 | 71.44 | 86.29 | 80.59 |
| Short-Term Debt | 13.06B | 10.91B | 11.27B | 557.41M | 1.91B | 1.49B | 2.25B | 2.77B | 3.13B | 2.06B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 88.44M | 55.34M | 204.67M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.51B | 1.54B | 1.57B | 955.21M | 1.37B | 5.25B | 5.37B | 4.1B | 5.6B | 4.1B |
| Current Ratio | 0.71x | 0.94x | 0.93x | 1.44x | 1.20x | 1.56x | 1.42x | 1.53x | 1.31x | 1.31x |
| Quick Ratio | 0.48x | 0.58x | 0.56x | 0.97x | 0.91x | 0.91x | 0.85x | 1.02x | 0.83x | 0.83x |
| Cash Conversion Cycle | -1.14 | 40.17 | 20.5 | 5 | 7.25 | 58.09 | 27.94 | 24.54 | -0.64 | 13.25 |
| Total Non-Current Liabilities | 27.06B | 28.69B | 30.17B | 11.92B | 11.85B | 61.17B | 57.76B | 63.97B | 77.58B | 68.2B |
| Long-Term Debt | 22.36B | 24.22B | 26.61B | 9.97B | 9.28B | 49.56B | 47.33B | 53.21B | 66.28B | 57.15B |
| Capital Lease Obligations | 187.82M | 0 | 90.79M | 497.33M | 445.26M | 2.48B | 3.2B | 2.96B | 3.31B | 12.79B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 67.87M | 348.58M | 2.12B | 1.89B | 2.35B | 0 | 2.23B |
| Other Non-Current Liabilities | 4.03B | 4.48B | 3.46B | 1.39B | 1.7B | 6.74B | 5.33B | 5.45B | 7.99B | 28.94B |
| Total Liabilities | 50.1B | 47.26B | 53.28B | 15.96B | 17.32B | 86.36B | 81.94B | 88.46B | 105.85B | 90.56B |
| Total Debt | 36.28B | 35.13B | 37.97B | 11.02B | 11.64B | 54.21B | 53.83B | 59.91B | 73.72B | 63.24B |
| Net Debt | 29.58B | 31.35B | 32.42B | 8.69B | 8.97B | 45.53B | 41.36B | 45.72B | 58.74B | 56.57B |
| Debt / Equity | 21.08x | 6.42x | 6.42x | 11.24x | - | 8.74x | 8.81x | 18.27x | - | -19.93x |
| Debt / EBITDA | 4.12x | 2.84x | 3.34x | 2.90x | 1.13x | 1.73x | 4.96x | 17.33x | 15.47x | 23.04x |
| Net Debt / EBITDA | 3.36x | 2.53x | 2.85x | 2.29x | 0.87x | 1.45x | 3.81x | 13.23x | 12.32x | 12.32x |
| Interest Coverage | 2.77x | 3.97x | 3.73x | 0.21x | 9.90x | 8.52x | 1.84x | -0.37x | 0.19x | -0.25x |
| Total Equity | 1.72B▲ 0% | 5.47B▲ 218.1% | 5.91B▲ 8.0% | 980.61M▼ 83.4% | -744.39M▼ 175.9% | 6.2B▲ 933.4% | 6.11B▼ 1.5% | 3.28B▼ 46.3% | -4.28B▼ 230.5% | -3.17B▲ 0% |
| Equity Growth % | 81.99% | 218.05% | 8.01% | -83.41% | -175.91% | 933.41% | -1.54% | -46.32% | -230.47% | -840.52% |
| Book Value per Share | 4.33 | 13.75 | 14.85 | 2.46 | -1.87 | 15.56 | 15.32 | 8.23 | -10.73 | -7.96 |
| Total Shareholders' Equity | 2.74B | 6.3B | 6.79B | 1.21B | -423.99M | 7.87B | 7.32B | 3.99B | -4.78B | -3.53B |
| Common Stock | 8.04B | 8.04B | 8.04B | 2B | 1.55B | 8.04B | 8.04B | 8.04B | 8.04B | 8.04B |
| Retained Earnings | 834.62M | 3.73B | 4.67B | 349.86M | -967.18M | 0 | 0 | -2.74B | -14.03B | -13.62B |
| Treasury Stock | -49.82M | -49.82M | -49.82M | -12.36M | -9.57M | -38.2M | -28M | -10M | 0 | 0 |
| Accumulated OCI | -6.09B | -5.42B | -5.88B | -1.12B | -995.75M | 317.25M | -244M | -852M | 1.7B | 2.04B |
| Minority Interest | -1.02B | -827.5M | -876.4M | -233.82M | -320.4M | -1.66B | -1.21B | -713M | 504M | 360M |
BAK Cash Flow Statement
Braskem S.A. (BAK) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.75B | 2.46B | 9.25B | 2.27B | 6.29B | 14.79B | 8.95B | -2.27B | 2.44B | 2.44B |
| Operating CF Margin % | 9.96% | 5% | 15.95% | 4.33% | 10.75% | 14% | 9.27% | -3.22% | 3.15% | - |
| Operating CF Growth % | -41.59% | -48.14% | 275.78% | -75.51% | 177.8% | 134.97% | -39.46% | -125.38% | 207.17% | -467.2% |
| Net Income | -99.25M | 5.42B | 3.65B | -4.6B | -6.69B | 13.98B | 47M | -4.58B | -17.73B | -5.24B |
| Depreciation & Amortization | 2.86B | 3.03B | 3.08B | 3.63B | 4.22B | 4.87B | 4.73B | 5.21B | 4.95B | 4.65B |
| Stock-Based Compensation | 0 | 0 | 4.4M | 0 | 7.46M | 14.39M | 0 | 10M | 0 | 0 |
| Deferred Taxes | 0 | 0 | -519.83M | -1.9B | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.88B | 2.5B | 6.3B | 5.42B | 10.28B | 8.39B | 203M | 1.05B | 14.66B | 1.35B |
| Working Capital Changes | -1.04B | -5.45B | -179.86M | -279.99M | -1.53B | -12.48B | 3.97B | -3.96B | 557M | -558M |
| Change in Receivables | 1.01B | -1.6B | 130.11M | 1.82B | -2.19B | -2.18B | 4.65B | 72M | 609M | 203M |
| Change in Inventory | 862.34M | -1.56B | -1.54B | 867.82M | -252.53M | -7.57B | 2.14B | 1.81B | -181M | 1.29B |
| Change in Payables | -4.25B | -1.44B | 1.34B | 282.44M | 0 | 0 | 514M | 0 | 384M | -492M |
| Cash from Investing | -2.84B | -2.41B | -2.49B | -2.67B | -2.72B | -3.38B | -4.95B | -4.53B | -3.48B | -3.35B |
| Capital Expenditures | -2.87B | -2.27B | -2.71B | -2.68B | -2.76B | -3.42B | -4.85B | -4.53B | -3.76B | -3.6B |
| CapEx % of Revenue | 6.03% | 4.61% | 4.67% | 5.13% | 4.71% | 3.24% | 5.02% | 6.42% | 4.86% | - |
| Acquisitions | 35.78M | -608.18M | 2.25M | 0 | 0 | 0 | -107M | -78M | 203M | 203M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -35.22M | 39.66M | 136.92M | 16.1M | 37.96M | 40.65M | 72.97M | 83M | 73M | 52M |
| Cash from Financing | -2.76B | -2.99B | -4.6B | 1.64B | 2.17B | -16.97B | 225M | 8.87B | 469M | 424M |
| Debt Issued (Net) | -759.33M | -1.99B | -3.1B | 1.81B | 2.71B | -10.97B | 1.55B | 8.28B | 437M | 440M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -2B | -998.89M | -1.5B | -668.9M | -2.38M | -5.99B | -1.35B | -7M | -6M | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 500M | -534.46M | 0 | 21M | 596M | 38M | -16M |
| Net Change in Cash | -265.25M▲ 0% | -2.93B▼ 1003.4% | 1.77B▲ 160.6% | 1.26B▼ 29.1% | 7.06B▲ 461.9% | -5.18B▼ 173.4% | 3.79B▲ 173.0% | 1.72B▼ 54.5% | 799M▼ 53.6% | -5.26B▲ 0% |
| Free Cash Flow | 1.87B▲ 0% | 188.42M▼ 89.9% | 6.54B▲ 3373.1% | -417.25M▼ 106.4% | 3.53B▲ 946.8% | 11.37B▲ 221.7% | 4.1B▼ 63.9% | -6.8B▼ 265.7% | -1.33B▲ 80.5% | -6.08B▲ 0% |
| FCF Margin % | 3.93% | 0.38% | 11.28% | -0.8% | 6.04% | 10.76% | 4.25% | -9.64% | -1.71% | -8.25% |
| FCF Growth % | -53.77% | -89.93% | 3373.06% | -106.38% | 946.79% | 221.67% | -63.89% | -265.74% | 80.51% | -357.44% |
| FCF per Share | 4.71 | 0.47 | 16.44 | -1.05 | 8.88 | 28.51 | 10.30 | -17.08 | -3.33 | -3.33 |
| FCF Conversion (FCF/Net Income) | -11.53x | 0.60x | 3.23x | -0.89x | -0.94x | 1.06x | -26.64x | 0.50x | -0.22x | 1.16x |
| Interest Paid | 0 | 0 | 0 | 0 | 2.74B | 2.88B | 0 | 3.55B | 0 | 2.3B |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BAK Key Ratios
Braskem S.A. (BAK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -30.87% | 113.52% | 50.36% | -73.74% | -5665.67% | 512.32% | -5.46% | -97.56% | - | 144.54% |
| Return on Invested Capital (ROIC) | 13.22% | 20.61% | 16.57% | 0.53% | 58.82% | 68% | 9.24% | -2.72% | 1.47% | 1.47% |
| Gross Margin | 26.69% | 26.11% | 19.99% | 12.32% | 18.95% | 30.35% | 11.77% | 4.28% | 7.75% | 4.41% |
| Net Margin | -0.86% | 8.29% | 4.94% | -4.86% | -11.43% | 13.24% | -0.35% | -6.49% | -14.62% | -7.1% |
| Debt / Equity | 21.08x | 6.42x | 6.42x | 11.24x | - | 8.74x | 8.81x | 18.27x | - | -19.93x |
| Interest Coverage | 2.77x | 3.97x | 3.73x | 0.21x | 9.90x | 8.52x | 1.84x | -0.37x | 0.19x | -0.25x |
| FCF Conversion | -11.53x | 0.60x | 3.23x | -0.89x | -0.94x | 1.06x | -26.64x | 0.50x | -0.22x | 1.16x |
| Revenue Growth | 0.81% | 3.35% | 17.74% | -9.79% | 11.89% | 80.42% | -8.62% | -26.89% | 9.7% | -1.58% |
BAK Frequently Asked Questions
Braskem S.A. (BAK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Braskem S.A. (BAK) reported $73.77B in revenue for fiscal year 2024. This represents a 5776% increase from $1.26B in 1998.
Braskem S.A. (BAK) grew revenue by 9.7% over the past year. This is steady growth.
Braskem S.A. (BAK) reported a net loss of $5.24B for fiscal year 2024.
Dividend & Returns
Braskem S.A. (BAK) does not currently pay a meaningful dividend. The company may be reinvesting profits for growth.
Braskem S.A. (BAK) had negative free cash flow of $6.08B in fiscal year 2024, likely due to heavy capital investments.
Explore More BAK
Braskem S.A. (BAK) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates